Screening and Management of Primary Aldosteronism: Closing the Gap in Hypertension Care episode artwork

EPISODE · Feb 26, 2026 · 22 MIN

Screening and Management of Primary Aldosteronism: Closing the Gap in Hypertension Care

from Medscape InDiscussion: Secondary Hypertension

Drs Marwah Abdalla and Vivek Bhalla discuss the screening, management, and future of primary aldosteronism — a common cause of secondary hypertension. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1003186. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Secondary Hypertension https://www.ncbi.nlm.nih.gov/books/NBK544305/ Primary Aldosteronism https://emedicine.medscape.com/article/127080-overview The Unrecognized Prevalence of Primary Aldosteronism: A Cross-Sectional Study https://pubmed.ncbi.nlm.nih.gov/32449886/ 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://pubmed.ncbi.nlm.nih.gov/40811516/ Expanding the Search for Primary Aldosteronism in Clinical Settings https://pubmed.ncbi.nlm.nih.gov/40811492/ Primary Hyperaldosteronism in Hypertension https://www.escardio.org/Councils/Council-for-Cardiology-Practice-(CCP)/Cardiopractice/primary-hyperaldosteronism-in-hypertension Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline https://pubmed.ncbi.nlm.nih.gov/40658480/ Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys https://pubmed.ncbi.nlm.nih.gov/36375469/ The Effect of Spironolactone on Morbidity and Mortality in Patients With Severe Heart Failure. Randomized Aldactone Evaluation Study Investigators https://pubmed.ncbi.nlm.nih.gov/10471456/ Cardiometabolic Outcomes and Mortality in Medically Treated Primary Aldosteronism: A Retrospective Cohort Study https://pubmed.ncbi.nlm.nih.gov/29129576/ Aldosterone Synthase Inhibitors for Cardiorenal Protection: Ready for Prime Time? https://pubmed.ncbi.nlm.nih.gov/39557029/

Episode metadata supplied by the publisher feed · Published Feb 26, 2026

Embed this episode

Ready to play

Screening and Management of Primary Aldosteronism: Closing the Gap in Hypertension Care

0:00 22:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Medscape InDiscussion: Secondary Hypertension?

This episode is 22 minutes long.

When was this Medscape InDiscussion: Secondary Hypertension episode published?

This episode was published on February 26, 2026.

Can I download this Medscape InDiscussion: Secondary Hypertension episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!